• TRM (USD/COP)COP 3,461.92 +1.37% +COP 46.82Colombia's official exchange rate (Financial Superintendence), valid Nov 21 to Nov 23
  • EuroCOP 3,804.64 +1.37% +COP 51.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote
  • Mexican pesoCOP 181.56 +1.37% +COP 2.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote

Translational Development Acquisition and ProLogium amend their $3.9 billion merger agreement

FinanceInternationalTradingViewAI summary
Image: TradingView

Translational Development Acquisition and ProLogium signed an amendment to their merger agreement that sets ProLogium's equity value at $3.9 billion and establishes the number of shares used to determine the recapitalization factor. The amendment revises the share exchange, the post-closing board composition and voting structure, and moves the arbitration seat to Singapore. The transaction remains subject to closing conditions.

In 25 seconds

  • The amendment sets ProLogium's equity value at $3.9 billion.
  • It establishes the number of shares used to determine the recapitalization factor.
  • The amendment revises the share exchange and post-closing corporate governance.
Read the full story at TradingView

IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.

Comments

Be respectful. Comments reported by several people are hidden until a moderator reviews them.

You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.

    Keep reading